| ■ 영문 제목 : Global Hormone Refractory Prostate Cancer Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00131 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 81 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 호르몬 불응성 전립선암의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (화학 요법, 호르몬 요법, 면역 요법, 방사선 요법)와 용도별 시장규모 (병원, 외래 외과 센터, 전문 클리닉) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 호르몬 불응성 전립선암 시장 점유율 - 지역별 호르몬 불응성 전립선암 시장규모 - 주요지역의 종류별 시장규모 (화학 요법, 호르몬 요법, 면역 요법, 방사선 요법) - 주요지역의 용도별 시장규모 (병원, 외래 외과 센터, 전문 클리닉) - 미주의 호르몬 불응성 전립선암 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 호르몬 불응성 전립선암 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 호르몬 불응성 전립선암 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 호르몬 불응성 전립선암 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 호르몬 불응성 전립선암 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Astellas Inc, Sanofi S.A, Dendreon Corporation, Bayer AG, Johnson & Johnson - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Hormone Refractory Prostate Cancer will have significant change from previous year. By the most conservative estimates of global Hormone Refractory Prostate Cancer market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hormone Refractory Prostate Cancer market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Hormone Refractory Prostate Cancer market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Chemotherapy
Hormonal Therapy
Immunotherapy
Radiation Therapy
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Astellas Inc
Sanofi S.A
Dendreon Corporation, Bayer AG
Johnson & Johnson
1 Scope of the Report 2 Executive Summary 3 Hormone Refractory Prostate Cancer Market Size by Players 4 Hormone Refractory Prostate Cancer by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Hormone Refractory Prostate Cancer Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Hormone Refractory Prostate Cancer Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Chemotherapy Table 3. Major Players of Hormonal Therapy Table 4. Major Players of Immunotherapy Table 5. Major Players of Radiation Therapy Table 6. Hormone Refractory Prostate Cancer Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global Hormone Refractory Prostate Cancer Market Size by Type (2016-2021) & ($ Millions) Table 8. Global Hormone Refractory Prostate Cancer Market Size Market Share by Type (2016-2021) Table 9. Hormone Refractory Prostate Cancer Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global Hormone Refractory Prostate Cancer Market Size by Application (2016-2021) & ($ Millions) Table 11. Global Hormone Refractory Prostate Cancer Market Size Market Share by Application (2016-2021) Table 12. Global Hormone Refractory Prostate Cancer Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global Hormone Refractory Prostate Cancer Revenue Market Share by Players (2019-2021E) Table 14. Hormone Refractory Prostate Cancer Key Players Head office and Products Offered Table 15. Hormone Refractory Prostate Cancer Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Hormone Refractory Prostate Cancer Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global Hormone Refractory Prostate Cancer Market Size Market Share by Regions 2016-2021 Table 20. Americas Hormone Refractory Prostate Cancer Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Country (2016-2021) Table 22. Americas Hormone Refractory Prostate Cancer Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Type (2016-2021) Table 24. Americas Hormone Refractory Prostate Cancer Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Application (2016-2021) Table 26. APAC Hormone Refractory Prostate Cancer Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Region (2016-2021) Table 28. APAC Hormone Refractory Prostate Cancer Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Type (2016-2021) Table 30. APAC Hormone Refractory Prostate Cancer Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Application (2016-2021) Table 32. Europe Hormone Refractory Prostate Cancer Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Country (2016-2021) Table 34. Europe Hormone Refractory Prostate Cancer Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Type (2016-2021) Table 36. Europe Hormone Refractory Prostate Cancer Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of Hormone Refractory Prostate Cancer Table 45. Key Application and Potential Industries of Hormone Refractory Prostate Cancer Table 46. Key Challenges of Hormone Refractory Prostate Cancer Table 47. Key Trends of Hormone Refractory Prostate Cancer Table 48. Global Hormone Refractory Prostate Cancer Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global Hormone Refractory Prostate Cancer Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global Hormone Refractory Prostate Cancer Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global Hormone Refractory Prostate Cancer Market Size Market Share Forecast by Type (2021-2026) Table 52. Global Hormone Refractory Prostate Cancer Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global Hormone Refractory Prostate Cancer Market Size Market Share Forecast by Application (2021-2026) Table 54. Astellas Inc Details, Company Type, Hormone Refractory Prostate Cancer Area Served and Its Competitors Table 55. Astellas Inc Hormone Refractory Prostate Cancer Product Offered Table 56. Astellas Inc Hormone Refractory Prostate Cancer Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. Astellas Inc Main Business Table 58. Astellas Inc Latest Developments Table 59. Sanofi S.A Details, Company Type, Hormone Refractory Prostate Cancer Area Served and Its Competitors Table 60. Sanofi S.A Hormone Refractory Prostate Cancer Product Offered Table 61. Sanofi S.A Main Business Table 62. Sanofi S.A Hormone Refractory Prostate Cancer Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. Sanofi S.A Latest Developments Table 64. Dendreon Corporation, Bayer AG Details, Company Type, Hormone Refractory Prostate Cancer Area Served and Its Competitors Table 65. Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Product Offered Table 66. Dendreon Corporation, Bayer AG Main Business Table 67. Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. Dendreon Corporation, Bayer AG Latest Developments Table 69. Johnson & Johnson Details, Company Type, Hormone Refractory Prostate Cancer Area Served and Its Competitors Table 70. Johnson & Johnson Hormone Refractory Prostate Cancer Product Offered Table 71. Johnson & Johnson Main Business Table 72. Johnson & Johnson Hormone Refractory Prostate Cancer Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Johnson & Johnson Latest Developments List of Figures Figure 1. Hormone Refractory Prostate Cancer Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Hormone Refractory Prostate Cancer Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Hormone Refractory Prostate Cancer Market Size Market Share by Type in 2020 Figure 7. Hormone Refractory Prostate Cancer in Hospitals Figure 8. Global Hormone Refractory Prostate Cancer Market: Hospitals (2016-2021) & ($ Millions) Figure 9. Hormone Refractory Prostate Cancer in Ambulatory Surgical Centers Figure 10. Global Hormone Refractory Prostate Cancer Market: Ambulatory Surgical Centers (2016-2021) & ($ Millions) Figure 11. Hormone Refractory Prostate Cancer in Specialty Clinics Figure 12. Global Hormone Refractory Prostate Cancer Market: Specialty Clinics (2016-2021) & ($ Millions) Figure 13. Global Hormone Refractory Prostate Cancer Market Size Market Share by Application in 2020 Figure 14. Global Hormone Refractory Prostate Cancer Revenue Market Share by Player in 2020 Figure 15. Global Hormone Refractory Prostate Cancer Market Size Market Share by Regions (2016-2021) Figure 16. Americas Hormone Refractory Prostate Cancer Market Size 2016-2021 ($ Millions) Figure 17. APAC Hormone Refractory Prostate Cancer Market Size 2016-2021 ($ Millions) Figure 18. Europe Hormone Refractory Prostate Cancer Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Hormone Refractory Prostate Cancer Market Size 2016-2021 ($ Millions) Figure 20. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Country in 2020 Figure 21. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Type in 2020 Figure 22. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Application in 2020 Figure 23. United States Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Regions in 2020 Figure 27. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Type in 2020 Figure 28. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Application in 2020 Figure 29. China Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 33. India Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Country in 2020 Figure 36. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Type in 2020 Figure 37. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Application in 2020 Figure 38. Germany Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 39. France Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Application in 2020 Figure 46. Egypt Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Hormone Refractory Prostate Cancer Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 52. APAC Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 53. Europe Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 55. United States Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 56. Canada Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 57. Mexico Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 58. Brazil Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 59. China Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 60. Japan Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 61. Korea Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 63. India Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 64. Australia Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 65. Germany Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 66. France Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 67. UK Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 68. Italy Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 69. Russia Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 70. Spain Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 71. Egypt Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 72. South Africa Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 73. Israel Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 74. Turkey Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Hormone Refractory Prostate Cancer Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 호르몬 불응성 전립선암 시장예측 2021년-2026년] (코드 : LPI-2201K00131) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 호르몬 불응성 전립선암 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |